Electroporation of cytokines for cancer gene therapy.
Choo
Andrew Y
AY
Inovio Biomedical Corporation, Blue Bell, PA, USA.
Shedlock
Devon J
DJ
Muthumani
Karuppiah
K
D000818:Animals; D017951:Antigen Presentation; D016207:Cytokines / Q000235:genetics / Q000627:therapeutic use*; D004274:DNA, Recombinant / Q000008:administration & dosage* / Q000627:therapeutic use; D018274:Electroporation; D005354:Fibrosarcoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000627:therapeutic use; D007156:Immunologic Memory; D007271:Injections, Intradermal; D015552:Injections, Intralesional; D007371:Interferon-gamma / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D018664:Interleukin-12 / Q000235:genetics / Q000378:metabolism / Q000627:therapeutic use; D051379:Mice; D010957:Plasmids / Q000008:administration & dosage* / Q000235:genetics / Q000627:therapeutic use; D012983:Soft Tissue Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D016207:Cytokines; D004274:DNA, Recombinant; D018664:Interleukin-12; D007371:Interferon-gamma